ArticleJournal of fluorescence2025
Antibacterial Efficacy of Tryptophan Coordinated Silver Nanoparticles Against E. coli: Spectroscopic and Microscopic Evaluation of Bacterial Cell Death.
Article in Journal of fluorescence, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The capability of conventional fluorescence spectroscopy and right-angled synchronous fluorescence spectroscopy (SFS) was evaluated to quantify the antibacterial potential of chemically synthesized Tryptophan coordinated silver nanoparticles (Ag-TrpNPs). Silver nanoparticles have gained significant importance as a material of interest due to their diverse assemblies in the nanoscale range and their potent antibacterial activity. But due to toxicity of silver nanoparticles there is a dire need to coordinate these materials with some biocompatible and biodegradable molecules. The study has been focused on chemical synthesis of functional fluorescence nanomaterials based on Tryptophan molecules coordinated with silver nanoparticles (Ag-TrpNPs). The antibacterial activity of Ag-TrpNPs was assessed in bacteria due to their functional characteristics such as tuneability, biocompatibility, and bioavailability. We employed optical characterization techniques such as Ultraviolet-visible spectroscopy, dynamic light scattering (DLS), scanning electron microscopy (SEM), Fourier-transform infrared spectroscopy (FTIR), fluorescence spectroscopy, and confocal microscopy to ensure the particles formation in aqueous suspension. DLS analysis confirmed the hydrodynamic size of the nanoparticles of approximately 100 nm. SEM images revealed the spherical morphology and size distribution of the Ag-TrpNPs. Escherichia coli bacterial strains were used to assess the antibacterial efficacy of the Ag-TrpNPs using fluorescence spectroscopy and imaging. Initially, the agar well plate method was employed to evaluate the antimicrobial activity of the Ag-TrpNPs. The significant zones of inhibition of size 37 mm at 500 µg/mL and 27 mm at 15.5 µg/mL were reported which indicated the efficiency of Ag-TrpNPs from higher to lower concentration. Conventional and synchronous fluorescence spectra provided evidence of bacterial cell death in aqueous suspensions to ensure the interaction of Ag-TrpNPs with E. coli bacteria at different times and concentrations. SEM was employed to investigate the interaction mechanism between Ag-TrpNPs and bacterial cells. The images revealed cell wall disintegration, leading to the leakage of cellular contents, and eventually cell death occurred.
Indexed as
Identifiers
39404916What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.